Minang Pravin Turakhia, M.D. M.A.S.

Curriculum Vitae

Minang Pravin Turakhia, M.D. M.A.S.

Revised 1/24/2013

Other names: Mintu Turakhia Work Address: 3801 Miranda Ave.

Cardiology – 111C Palo Alto, CA 94304 Tel (650) 858-3932 [email protected]

EDUCATION 1992-1996 University of California, Berkeley B.A. Molecular Biology 1992-1996 University of California, Berkeley Minor Computer Science 1996-2000 University of California, San Francisco M.D. Medicine 2005-2008 University of California, San Francisco M.A.S. Clinical Research & Biostatistics POSTGRADUATE TRAINING 2000-2001 Brigham & Women’s Hospital (Harvard) Internship Internal Medicine 2001-2003 Brigham & Women’s Hospital (Harvard) Residency Internal Medicine 2003-2006 University of California, San Francisco Fellowship Cardiology 2006-2008 University of California, San Francisco Fellowship Cardiac Electrophysiology PRINCIPAL POSITIONS HELD Academic 2008- Instructor of Medicine (Affiliated), Stanford University Clinical 2009- Director, Cardiac Electrophysiology, VA Palo Alto Health Care System 2009- Director, Atrial Fibrillation Program, VA Palo Alto Health Care System 2008- Attending Physician, Cardiac Arrhythmia Service, Stanford Hospital & Clinics Research 2008- Investigator, VA Center for Health Care Evaluation 2009- Investigator, Chronic Heart Failure Quality Enhancement Research Initiative 2007-2010 Chair of Clinical Research, South Asian Heart Center LICENSURE & CERTIFICATION 1998-2001 United States Medical Licensing Exam (USMLE) Steps I, II, III 2001 Massachusetts state medical license # 00-206778-03 2003 California state medical license # A83028 2003 California state fluoroscopy license # RHC161576 2003 Federal Drug Enforcement Agency (DEA # FT3393434) 2003 Board Certification, Internal Medicine, ABIM 2003 National Provider Identifier (NPI) # 1528114204 2006 Board Certification, Cardiovascular Disease, ABIM 2009 Board Certification, Clinical Cardiac Electrophysiology, ABIM HONORS & AWARDS 1992 Salutatorian, John F. Kennedy High School 1992 Bank of America Foundation Liberal Arts Award 1992 Josten’s Foundation Scholar 1992 Knight-Ridder Scholar

1992 Lion’s Club of America Scholarship 1992 Tylenol Academic Merit Scholarship

Mintu Turakhia, M.D. M.A.S. page 2

1992-1996 University of California Dean’s List (8/8 semesters) 1992, 1993, 1994 University of California Alumni Leadership Award 1996 Golden Key Honors Society 1996 INSIGHT Advanced Professional Leadership Award (McKinsey & Co.) 1996 UC Berkeley Graduation with High Honors 1997 UCSF V.B. Nelson Scholarship 2000 Alpha Omega Alpha medical honors society 2003 Educational Grant, Millenium Pharmaceuticals 2003 Young Investigator Research Travel Grant (Pfizer Corporation) 2004 Highest cardiology shelf exam score in UCSF fellowship program 2005 American College of Cardiology / Merck Foundation (ACC-Merck) Adult

Cardiology Fellowship Research Award 2005 Finalist, Laennec Society Young Clinician Award, AHA 2005, 2006, 2007 Recipient, NIH Postdoctoral Clinical Research Loan Repayment Grant 2007 First Place, Krishna Ramaswamy Young Investigator Award, American Assoc. of

Cardiologists of Indian Origin 2009 Recipient, "Who's Who in America: Physicians" 2010 E. William Hancock Stanford Cardiovascular Medicine Faculty Teaching Award 2010 Mentor, Stanford Cardiology Fellow Clinical Research Award 2010 Stanford School of Medicine Divisional Teaching Award 2011 Judge, AHA QCOR Young Investigators Competition 2011 Mentor for Finalist of Northwestern Young Investigators Forum 2011 Finalist for best poster competition, Bay Area Clinical Research Symposium 2012 Semi-finalist, best poster award, American College of Cardiology 2012 Sessions 2012 “AHA Top Ten Scientific Advances in Cardiology for 2011” for paper on cost-

effectiveness of dabigatran 2012 Participant, Team Science Series, Stanford University Office of Diversity and

Leadership 2012 American College of Cardiology Foundation Emerging Faculty Program KEYWORDS / AREAS OF INTEREST Atrial fibrillation, sudden cardiac death, arrhythmias, implantable cardioverter-defibrillators, cardiac

resynchronization therapy, catheter ablation, coronary heart disease, anticoagulation, stroke, outcomes research, health services research, epidemiology, clinical trials, quality of care, risk prediction, technology assessment

CLINICAL ACTIVITIES VA Palo Alto Health Care System Invasive Cardiac Electrophysiologist (perform invasive EP procedures (1.5 days/week) Attending Physician, Cardiac Arrhythmia/Electrophysiology Clinic (0.5 days/week) Stanford Hospitals & Clinics Attending Physician, Cardiac Electrophysiology Inpatient Service (6 weeks/year) Attending Physician, Cardiac Arrhythmia/Electrophysiology Clinic (0.5 days/month) Invasive Cardiac Electrophysiologist, Stanford Hospitals and Clinics Procedures Performed Catheter ablation for atrial fibrillation, atrial flutter, supraventricular tachycardia, ventricular

tachycardia; implantation of cardiac devices including pacemakers, implantable defibrillators (ICDs), cardiac resynchronization therapy (CRT), and loop recorders (ILR); lead extraction.


RESEARCH AWARDS & GRANTS: PEER-REVIEWED GRANTS: Pending Effectiveness of a Telemedicine System of A-Fib Alerts for Stroke Prevention Veterans Affairs Health Services & Research “Effectiveness of a Telemedicine System of A-Fib Alerts for Stroke Prevention” Role: PI $100,000 direct Active 1/2013-1/2015 Gilead Sciences Research Scholars Program in Cardiovascular Disease Gilead Sciences “Comparative effectiveness and safety of atrial fibrillation therapies in chronic

kidney disease” Role: PI $130,000 direct 8/2012-5/2016 National Institutes of Health NIDDK # 1R01DK095024-01A1 “The Atrial Fibrillation - Factor Identification to Risk Modification Study in HD” PI: Winkelmayer, W Role: Co-Investigator 7/2012-12/2014 Medtronic, Inc. “Relationship of Burden of Atrial Fibrillation to Stroke Risk” Role: PI $93,000 direct 5/2012-4/2013 iRhythm, Inc. “Diagnostic Yield and Outcomes with Extended-Duration Arrhythmia Monitoring” Role: PI $45,000 direct 7/2011-12/2013 Veterans Affairs Health Services & Research IIR #1I01HX000116-01A2 "Dual Use: Safe in Atrial Fibrillation?"

Role: PI $615,500 direct 9/2009-8/2014 Veterans Affairs Health Services & Research #CDA09027-1 "Optimizing Care of Atrial Fibrillation and Atrial Flutter in Veterans"

Role: PI $1,995,000 direct 7/2009-6/2013 American Heart Association – National Scientist Development Program

#09SDG2250647 “Performance Measures for Atrial Fibrillation and Flutter and National AF Outcomes Database” Role: PI $308,000 direct

6/2011-9/2013 Palo Alto Institute for Research and Education #TUM0005 "Creation of AF Risk Score and Pilot Screening Program for AF"

Role: PI $50,000 direct


SPONSORED (NON PEER-REVIEWED) RESEARCH: 12/2012- ST Monitoring to Detect ACS Events in ICD Patients (ANALYZE-ST) Sponsor: St Jude Medical Role: Site PI 12/2012- Global Registry on Long-Term Oral Anticoagulation IN AF (GLORIA-AF) Sponsor: Boehringer Ingelheim Role: Site PI 1/2011- Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF) Sponsor: Janssen Scientific Affairs

Role: Site PI Deferred American Heart Association – Western States Clinical Research Program

#09CRP2250652 “Performance Measures for Atrial Fibrillation and Flutter and National AF Outcomes Database” Role: PI

$154,000 direct Reason for deferral: Overlap with AHA National grant

Completed 2008-2010 Veterans Affairs Health Services & Research IIR #04-248 "Quality of Atrial Fibrillation Care in Mental Health Conditions"

PI: Frayne. Role: Co-Investigator $377,600 direct

2009 American Heart Association Student Scholarship Program "Predictors of metabolic syndrome in young South Asians" (PI: Prasad M) Role: Mentor 2006-2009 El Camino Hospital Foundation

“South Asian Heart Center Research Program” Role: PI

2007-2008 NIH Student Loan Repayment Program # L30 HL082386-02

"Combined Risk Score to Predict Risk of Sudden Death" Role: PI

2005-2007 NIH Student Loan Repayment Program # L30 HL082386-01

"Detection of Genetic Polymorphisms Contributing to Ventricular Arrhythmias and Sudden Cardiac Death" Role: PI

2005-2006 American College of Cardiology-Merck Postdoctoral Fellowship Award

"Detection of Genetic Polymorphisms Contributing to Ventricular Arrhythmias and Sudden Cardiac Death" Role: PI

1998-2000 UCSF Instructional Technology Grant (program funded by NIH and Howard

Hughes Medical Institute) "Development of instructional website for medical education" Role: PI

Research Skills


Statistics / Trials Formal training in advanced biostatistics, epidemiologic methods, clinical epidemiology, and STATA software. Experienced in clinical trial design. Proficient in creating and managing clinical research electronic databases.

Computer Data acquisition and analysis (LabVIEW, C++, STATA) Relational database design (FileMaker, SQL, Access) Programming languages (C, C++) Operating Systems (OS X, Unix, Linux, Windows) Web-page programming and design Computer Programming Experience 1992 Database development intern, Dialog Information Services, Palo Alto, CA 1994-1996 Information Technology Consultant, UC Berkeley

1994-1998 Creation of digital signal processing tools for analysis of electrophysiologic muscle data

1996-1999 Freelance software, database, web developer and consultant 1998-2000 Founder and creator, UCSF Missing Link medical education website and portal

(http://missinglink.ucsf.edu). Website was the first-ever academic medical education website and remains a focal point of UCSF’s medical school curriculum.

PROFESSIONAL ORGANIZATIONS Fellowships 2012 Fellow of the Heart Rhythm Society (FHRS) 2012 Fellow of the American College of Cardiology (FACC) Memberships 2002- American Heart Association 2003- Merck Fellow, American College of Cardiology 2005- Heart Rhythm Society Service to Professional Organizations

1995-1996 Board of Directors, UC Berkeley Student Health Advisory Committee 1996-1998 Fundraising Chairperson, UCSF Homeless Clinic 1996-1997 Staff writer, Synapse, UCSF student newspaper 1997, 1998 Chairperson, San Francisco South Asian Health Forum 1997, 1998 Chairperson, UCSF South Asian Health Professional Student Association

1998-1999 Medical school junior class co-chairman 1998-2000 Medical school technology committee

1999-2000 Medical school senior class co-chairman 2001-2003 Brigham and Women’s Hospital Residency Selection Committee

2002-2003 Brigham and Women’s Hospital Resident Well-Being Committee 2004 Chairperson, American College of Cardiology fellows in-training seminar 2005 UC Berkeley Alumni Association Scholarship Award selection committee 2006-2007 Clinical Expert Member, California Technology Assessment Forum 2006-2008 EP Fellows Educational Advisory Council, Boston Scientific Corporation 2006-2008 Young Clinicians & Investigator Committee, AHA Clinical Council 2008-2009 Selection Committee, Stanford Internal Medicine residency program 2009-2010 Co-Chairperson, 2010 VA HSR&D Career Development Award Conference 2010 Member, Atrial Fibrillation Expert Review Group, Institute for Clinical and

Economic Review 2010 Member, Working Group, Safety of Atrial Fibrillation Registry Initiative (SAFARI) 2010-2011 Member, VA National Task Force on Patient Laboratory Self-Testing 2011 Director, “Practicing EP on the West Coast: Strategies for Success”

Electrophysiology Fellows Education Program


2011 External Reviewer, Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy, American College of Cardiology

2008- Selection Committee, Stanford Cardiology fellowship training program 2008- Selection Committee, Stanford Electrophysiology fellowship training program 2009- Member, Heart Rhythm Society Clinical Research & Training Committee 2009- Member, AHA Electrocardiography and Arrhythmias Committee (Clinical Council)

2009- Advisory Board, Chronic Heart Failure Quality Enhancement Research Initiative 2010- Chair, Science Advisory Writing Group, AHA Telemetry Latency Advisory, AHA

Council of Clinical Cardiology 2010- Member, Young Clinicians and Investigator Committee, AHA Council of Quality of

Care and Outcomes Research 2010- Member, ICD Registry Research & Publications Subcommittee, ACC National

Cardiovascular Data Registry (NCDR) 2010- Member, AHA ECC Advanced Cardiac Life Support Subcommittee 2010- Member, Stanford Cardiovascular Institute Steering Committee 2011- Member, Heart Rhythm Society Advisory Panel 2011- Member, AHA Leadership Committee, AHA Council of Clinical Cardiology 2011- Co-Chair, Cardiac Electrophysiology Core, Stanford Cardiovascular Institute 2011- Co-Chair, Epidemiology Research Core, Stanford Cardiovascular Institute 2011-2012 Member, Writing Group, Science Advisory: Antithrombotic Therapies for Stroke

Prevention in Atrial Fibrillation, American Heart Association 2012 Planning committee, AHA-HRS Joint Sessions curriculum 2012-2013 Program committee, AHA Quality of Care and Outcomes Research Scientific

Sessions 2012- Member, Writing Group, Science Advisory: Wearable External Defibrillator

Therapy for the Prevention of Sudden Cardiac Arrest, American Heart Association

2012 Abstract Reviewer, American College of Cardiology 2013 Scientific Sessions 2012- Member, AHA Get With The Guidelines AF (GWTG-AF) Working Group

Service to Professional Publications

2007- Ad Hoc Reviewer for journals including Journal of the American Medical Association, Journal of Cardiac Failure, Journal of Hospital Medicine, American Heart Journal, American Journal of Cardiology, Journal of the American College of Cardiology, Archives of Internal Medicine, Journal of Electrocardiology, Circulation journals, Annals of Noninvasive Electrocardiology, Pacing and Clinical Electrophysiology

2008-09 Editorial Consultant, Physicians’ Information and Education Resource, American College of Physicians

2009- Deputy Online Content Editor, Journal of Interventional Cardiac Electrophysiology

2009- Associate Editor, Journal of Interventional Cardiac Electrophysiology 2009-2011 Associate Editor of Web Content, Archives of Internal Medicine 2011 Guest Editor, Health Policy Issue, Journal of Interventional Cardiac

Electrophysiology 2011 Guest Editor, Circulation: Quality of Care and Outcomes Research 2012 Editorial Board Member, Cardiovascular Business

INVITED PRESENTATIONS International

1. “Atrial fibrillation: emerging concepts and treatment paradigm.” Chinese Association of Structural Cardiology Annual Meeting. September 2008, Linyi, China.

2. “Test Performance of Microvolt T-Wave Alternans.” CARDIOSTIM Annual Meeting. June 2010. Nice, France.


National 1. “A clearer understanding of cardiovascular risk factors: The South Asian Heart Center

Experience.” March 2007, South Asian Heart Center Steering Committee Meeting, American College of Cardiology Annual Meeting.

2. Chair, TIE-ICC South Asian Wellness Forum Panel. TIE Conference. May, 2008. Santa Clara, CA.

3. “Impact of Renal Failure on Outcomes in Patients with Implantable Defibrillators.” Heart Rhythm Society 2008 Scientific Sessions. San Francisco, CA.

4. “Addressing Unmet Needs (and Reality) in EP Fellowship Training.” Biotronik National Fellows Advisory Council Meeting, December 2009. New York, NY.

5. “Quality and Outcomes in AF: A Paradigm Shift in Research.” Medtronic Scientific Forum, April 2010, Minneapolis, MN.

6. “Cardiac Resynchronization Therapy: Setting Up for Success.” The Practical Electrophysiologist: Tools to Hit the Ground Running, Electrophysiology Physician Education Program. June 5, 2010. New York, NY.

7. “Clinical Considerations: Pearls from The Experts.” Panel Discussion. The Practical Electrophysiologist: Tools to Hit the Ground Running, Electrophysiology Physician Education Program. June 5, 2010. New York, NY.

8. “The changing landscape of atrial fibrillation: methods of assessing effectiveness, quality, and costs.” Cardiology Grand Rounds, University of Pittsburgh School of Medicine. October 4, 2010. Pittsburgh, PA.

9. “Is the pacemaker working properly?” American College of Cardiology Scientific Sessions. April 5, 2011.

10. “Stroke prevention in atrial fibrillation.” Panel Discussion. American College of Cardiology Scientific Sessions. April 5, 2011.

11. “Strategies for Device and Trial Design Focused on Cost and Outcomes.” Stanford Biodesign New Arrhythmia Technologies Retreat. May 3, 2011. Stanford, CA.

12. “New Drugs for AF: Validating Efficacy by More Rigorous Monitoring.” Veterans Affairs National Cardiac Electrophysiology Meeting. May 4, 2011. San Francisco, CA.

13. “Cardiac Resynchronization Therapy: New Evidence, More Questions.” Department of Veterans Affairs Patient Care Services Optimizing Efficiency and Quality of Cardiovascular Care Conference. July 12, 2011. Denver, CO.

14. “Strategies for Device Development Focused on Cost and Outcomes.” Boston Scientific Corporation Grand Rounds, July 15, 2011. Minneapolis, MN.

15. “Health Policy, Reform, and Comparative Effectiveness Research: Implications for Electrophysiology.” East Cost Electrophysiology Summit. September 25, 2011. New York, NY.

16. “Impact of Health Care Reform on Arrhythmia Care.” Hawaii Electrophysiology Summit. October 2, 2011. Maui, HI.

17. “Cost-effectiveness of stroke prevention therapies for atrial fibrillation.” American Heart Association Scientific Sessions. November 14, 2011. Orlando, FL.

18. “Newer Oral Anticoagulants and Percutaneous Left Atrial Appendage Closure to Prevent Strokes in Patients with Atrial Fibrillation.” 28th Annual ACC Advances in Heart Disease Course. December 16, 2011. San Francisco, CA.

19. “Appropriate Use of Implantable Cardioverter-Defibrillators.” 28th Annual ACC Advances in Heart Disease Course. December 16, 2011. San Francisco, CA.

20. “Methods to evaluate quality, effectiveness, and costs of treatment of atrial fibrillation.” Department of Epidemiology Grand Rounds. Washington University at St. Louis. February 3, 2012. St. Louis, MO.

21. “Using large-scale observational data to answer clinical questions for treatment of atrial fibrillation. March 1, 2012. Frontiers of Cardiovascular Science. Cardiovascular Institute, Stanford University. Stanford, CA.

22. “Coronary Disease in South Asians: Why is it so prevalent and what can we do?” UCSF Asian Heart & Vascular Symposium. San Francisco, CA. February 2012.

23. “Health Care Policy and Reform: Implications for Arrhythmia Care.” Advanced Concepts in Electrophysiology Meeting. Washington, DC. March 2012.


24. “Outcomes Research and Health Policy in Electrophysiology: Implications for Device Development.” Research Lyceum Visiting Speaker. St Jude Medical. Sylmar, CA. April 2012.

25. “Defining the unmet needs for stroke prevention in AF: are the new drugs enough?” Stanford Biodesign New Arrhythmia Technologies Retreat. Boston, MA. May 2012.

26. “Health care policy and reform: implications for arrhythmia care.” St. Jude Medical Allied Health Professional Symposium. Boston, CA. May 2012.

27. “Implementation and comparative effectiveness of new oral anticoagulants.” Veterans Administration Arrhythmia/Device National Meeting. Boston, CA. May 2012.

28. “Methods to evaluate quality, effectiveness and outcomes of the treatment of atrial fibrillation.” Stanford University School of Medicine faculty candidate seminar. May 18, 2012. Stanford, CA.

29. “Healthcare Economics in Today’s Changing Environment.” Southwest Arrhythmia Patient Management Symposium. October 6, 2012. Newport Beach, CA.

30. “Health Care Policy and Reform: Implications for Arrhythmia Physicians.” The Standard of Care Physician Program. November 30, 2012. New York, NY.

31. “Cost Effectiveness of Implantable Defibrillators.” Electrophysiology Physician Symposium. December 1, 2012. San Diego, CA.

Regional

1. “62-year old man with fever, rash, and polyarthritis.” January 2003, Brigham & Women’s Hospital Department of Medicine Clinicopathologic Conference, Boston, MA.

2. “Novel therapies for increasing HDL.” March 2004, University of California San Francisco, Division of Cardiology, San Francisco, CA.

3. “Cardiovascular risk in South Asians.” July 2005, Federation of Jain Associations in North America, Santa Clara, CA.

4. “Heart disease in Indians living in America.” November 2005, Jain Center of Northern California, Milpitas, CA.

5. “Update on cardiovascular disease in South Asians.” June 2006, American Associations of Physicians of Indian Origin California Chapter Annual Meeting, Fremont, CA.

6. “Atrial Flutter,” April 2007. UCSF Department of Nursing Cardiovascular Seminar. 7. “Epidemiology of Cardiovascular Risk Factors in Bay Area South Asians: Findings from the

South Asian Heart Center,” September 2007. Coronary Artery Disease Pandemic: Strategies & Solutions Symposium. San Jose, CA.

8. “Clinical Cases” (moderator). September 2007. Coronary Artery Disease Pandemic: Strategies & Solutions Symposium. San Jose, CA.

9. “Heart Disease in South Asians: Identification of an Unmet Clinical Need.” November, 2007. American Association of Indian Cardiologists Scientific Sessions. Orlando, CA.

10. “Cardiovascular Disease in South Asians in America: What Do We Know?” November, 2007. UCSF Asian Heart & Vascular Symposium. San Francisco, CA.

11. “Cardiovascular Disease and Genetics in South Asians” December 2007. Celera Genomics. Emeryville, CA.

12. “Cardiovascular disease in South Asians: New Approaches to Risk Stratification: March, 2008. American College of Cardiology California Chapter Meeting. San Francisco, CA.

13. “Beyond MI in South Asians: Arrhythmias, Sudden Death, and Stroke.” South Asian Heart Center Symposium. September, 2008. San Jose, CA.

14. “Tough ICD, Pacemaker, and CRT Cases: Device Troubleshooting.” Electrophysiology in the West Summit, Stanford University. December 2008. Monterey, CA.

15. “Arrhythmia Controversies and Challenging Cases.” Electrophysiology in the West Summit, Stanford University. December 2008. Monterey, CA.

16. “Cardiovascular Disease in South Asians: Update.” UCSF Asian Heart & Vascular Symposium. February 2009. San Francisco, CA.

17. "Thunder & Lightning: Management of Electrical Storm." Stanford University Allied Professional Arrhythmia Symposium. March 2009. Palo Alto, CA.

18. "Robotic Navigation: Which Patients, Which Systems." Stanford University Allied Professional Arrhythmia Symposium. March 2009. Palo Alto, CA.

19. “Contemporary Management of Ventricular Tachycardia.” Northern California Veterans Affairs Cardiovascular Symposium. June 2009. Palo Alto, CA.


20. “Treatment of Atrial Fibrillation: Quality of Care, Outcomes, and Comparative Effectiveness.” American College of Cardiology Northern California Chapter Conference. June 2009. San Francisco, CA.

21. "Study and Clinical Trial Design: A Primer for Entrepreneuers." Stanford Biodesign Program. August 2009. Palo Alto, CA.

22. “Primer of Epidemiology: Study Design.” Stanford University Cardiology Core Conference. August 25, 2010. Stanford, CA.

23. “Measures of Association and Risk.” Stanford University Cardiology Core Conference. September 8, 2010. Stanford, CA.

24. “Clinical Trials.” Stanford Biodesign Program. September 2009. Palo Alto, CA. 25. “Risk Prediction for Sudden Cardiac Death: What’s the Future?” Stanford ICD Patient Day.

October 2009. Palo Alto, CA. 26. “Ventricular tachycardia storm.” Stanford University Electrophysiology in the West Summit.

December 2009. Palo Alto, CA. 27. “Health Reform and Electrophysiology: The Case of Sudden Death and Atrial Fibrillation.”

Stanford University Electrophysiology in the West Summit. December 2009. Palo Alto, CA. 28. “Ventricular tachycardia storm.” Stanford University Electrophysiology in the West Summit.

December 2009. Palo Alto, CA. 29. “My Most Challenging Cases.” Stanford University Electrophysiology in the West Summit.

December 2009. Palo Alto, CA. 30. “Introduction to Pacemakers: From an Engineer’s Perspective.” Stanford University Vascular and

Cath Lab Rounds. December 2009. Palo Alto, CA. 31. “How to Stay Up-To-Date with the Medical Literature.” Stanford University Cardiology Fellows

Conference. January 2010. Palo Alto, CA. 32. “Strategies to Reduce ICD Shock Burden.” Stanford University Allied Health Arrhythmia Meeting.

January 2010. Palo Alto, CA. 33. “Atrial Fibrillation.” Stanford Community Health Forum. February 2010. Palo Alto, CA. 34. “MedTech 101.” Piper Jaffray Symposium. February 2010. Palo Alto, CA. 35. “Cardiovascular Disease in South Asians: Update.” Asian Heart and Vascular Symposium.

February 27, 2010. San Francisco, CA. 36. “What is a P value?” Stanford University Cardiology Core Conference. March 23, 2010. Stanford,

CA. 37. “Randomized Clinical Trials.” Stanford University Cardiology Core Conference. April 13, 2010.

Stanford, CA. 38. “How to Keep Up with the Medical Literature. Stanford University Cardiology Core Conference.

May 3, 2010. Stanford, CA. 39. “Treatment of Atrial Fibrillation: What’s Behind the Smoke and Mirrors.” Cardiology Grand

Rounds, Stanford University. May 7, 2010. Stanford, CA. 40. “Treatment of Atrial Fibrillation in Veterans: Methods to Assess Effectiveness and Cost

Effectiveness.” Center for Health Care Evaluation Forum. May 25, 2010. Menlo Park, CA. 41. “Atrial fibrillation and stroke prevention.” VA Palo Alto Health Care System Multidisciplinary

Conference. August 30, 2010. Palo Alto, CA. 42. “Cardiac devices.” VA Palo Alto Health Care System. September 28, 2010. Palo Alto, CA. 43. “Risk stratification and treatment for sudden cardiac death.” Stanford University Department of

Medicine. September 29, 2010. Stanford, CA. 44. "FDA device outcomes trials: how to design studies for regulatory approval." Stanford Biodesign

Program. October 28, 2010. Stanford, CA. 45. “The Changing Landscape of Atrial Fibrillation: Methods of Assessing Effectiveness, Quality, and

Costs.” Stanford Cardiovascular Institute. December 1, 2010. Stanford, CA. 46. “Stroke prevention in atrial fibrillation in 2010 and beyond.” Electrophysiology in the West

Summit. December 10, 2010. Monterey, CA. 47. “Management of Electrical Storm.” Electrophysiology in the West Summit. December 10, 2010.

Monterey, CA. 48. “Primer of Intracardiac Tracings.” Electrophysiology in the West Summit. December 11, 2010.

Monterey, CA.


49. “How to identify patients that need cardiac resynchronization therapy.” Electrophysiology in the West Summit. December 11, 2010. Monterey, CA.

50. “Catastrophic Complications in the EP Lab.” Practicing EP on the West Coast: Strategies for Success Fellows Program. January 28, 2011. San Francisco, CA.

51. “Preparing for an Academic Career.” Practicing EP on the West Coast: Strategies for Success Fellows Program. January 28, 2011. San Francisco, CA.

52. “Atrial Fibrillation: Methods to Assess of Quality and Outcomes of Care.” Stanford Prevention Research Center / General Medical Disciplines Seminar Series. April 21, 2011. Stanford, CA.

53. “Differentiating AVNRT and JT.” Stanford Cardiac Electrophysiology Conference. May 26, 2011. Stanford, CA.

54. “Management of post-operative atrial fibrillation.” Stanford Cardiology Conference. August 2, 2011. Stanford, CA.

55. “Implantable defibrillators and sudden cardiac death.” VA Palo Alto Health Care System. August 9, 2011. Palo Alto, CA.

56. “Risk stratification and treatment for sudden cardiac death.” Stanford University Department of Medicine. August 9, 2011. Stanford, CA.

57. “Effectiveness of Cost-Effectiveness of Emerging therapies for stroke prevention in atrial fibrillation.” VA California Pharmacy and Pharmacoeconomics Symposium. August 29, 2011. Monterey, CA.

58. “Electrophysiologic maneuvers for supraventricular tachycardia.” Stanford Cardiac Electrophysiology Conference. October 13, 2011. Stanford, CA.

59. “Linking large datasets (VA and Medicare) to understand dual health care system use, quality of care, and outcomes in patients with atrial fibrillation.” University of California San Francisco Cardiovascular Outcomes Research Group Seminar. December 1, 2011. San Francisco, CA.

60. “New stroke prevention therapies: a clinical primer.” Stanford Cardiac Electrophysiology Conference. January 19, 2012. Stanford, CA.

61. "The mega-cohort: linking large datasets for quality and outcomes research for heart rhythm disorders." Center for Health Care Evaluation Forum. February 7, 2012. Menlo Park, CA.

62. “Challenging device tracings.” Bay Area Peninsula Electrophysiology Meeting. February 28, 2012. Palo Alto, CA.

63. “Coronary Disease in South Asians: Why is it so prevalent and what can we do?” Apple Computer Inc. March 13, 2012. Cupertino, CA.

64. “Brugada syndrome presenting as seizure” (discussant). Multidisciplinary conference. VA Palo Alto. March 14, 2012. Palo Alto, CA.

65. “Quality and outcomes in the treatment of atrial fibrillation.” CHF QUERI Meeting. April 10, 2012. Burlingame, CA.

66. “Challenging supraventricular tachycardia cases.” CARDIA: Cardiac Arrhythmias, Sudden Death, Inherited Disease, Athletes. June 22, 2012.

67. “Across the Arrhythmia Spectrum: from ED to Discharge – Case Study Presentations.” CARDIA: Cardiac Arrhythmias, Sudden Death, Inherited Disease, Athletes. June 22, 2012.

68. Supraventricular tachycardia. VA Arrhythmia Teaching Conference. July 13 2012. 69. “Risk stratification and treatment for sudden cardiac death.”. August 7, 2011. Stanford, CA. 70. “Implantable defibrillators and sudden cardiac death.” Stanford University Department of

Medicine and VA Palo Alto Health Care System. August 7, 9, 2012. Palo Alto, CA. 71. “ECG emergencies.” Stanford University Department of Medicine and VA Palo Alto Health Care

System. August 18, 20, 2012. Palo Alto, CA. 72. “Differentiating junctional tachycardia from atrioventricular nodal reentrant tachycardia.” Stanford

University Cardiac Electrophysiology Conference. October 4, 2012. Stanford, CA. 73. “Large-Scale Comparative Effectiveness Research: How to Study Treatments When You Can’t

Do A Clinical Trial.” Stanford University School of Medicine MED 223 course. January 9, 2013. Stanford, CA.

MEDIA AND PRESS COVERAGE Television

1. “Heart disease in South Asians: Part I.” Echoes of Asia live program interview (30 minutes). Televised on May 22, 2006, Comcast Bay Area Public Access Channel.


2. “Heart disease in South Asians: Part II.” Echoes of Asia live program interview (30 minutes). Televised on May 24, 2006, Comcast Bay Area Public Access Channel.

Print Coverage

1. “Lasting impressions: Turakhia on challenges of treating heart condition in pregnancy.” Inside Stanford Medicine. April 12, 2010.

2. “Using genetics to make an electrical diagnosis of the heart.” Inside Stanford Magazine. November 7, 2011.

Online Coverage

1. “Real World and RELY: More Evidence on Stroke Prevention.” theheart.org accredited education program. December 7, 2012. [http://theheart.medscape.org/viewprogram/32699]

2. “Stanford Center for Inherited Cardiovascular Disease gets to the heart of dangerous mutations.” Stanford School of Medicine. January 9, 2012. [http://med.stanford.edu/ism/2012/january/inherited-cv-0109.html]

TEACHING 1996 Undergraduate course instructor, Department of South and Southeast Asian

Studies, UC Berkeley 1996-1998 Volunteer science tutor, San Francisco School District 2003 Course instructor, Internal Medicine block, Harvard Medical School 2003 Preceptor, Introduction to Clinical Medicine, Harvard Medical School 2004-2006 Course instructor, Cardiovascular Physiology, UCSF Medical School

2005-2007 Staff writer, Medcompare.com 2007-2008 Course instructor, Evidence-Based Medicine, UCSF Medical School 2007-2008 Lecturer, ECG Course for Fourth-Year Medical Students 2008 Small group leader, Health Policy, Fourth-Year Medical Students 2008 Teaching assistant, UCSF Outcomes Research graduate course 2008-2010 Cardiac Arrhythmia Teaching Rounds (1 hour/week) 2008-2010 Cath/EP Lab Staff Teaching Seminar (1 hour/week) 2008-2010 Medical Student ECG teaching (1 hour/month) 2009-2010 Electrophysiology Fellows Teaching Seminar (1 hour/week) 2008- Lecturer, Stanford University Biodesign Program (2 hours/month) 2008- Cardiac Arrhythmia Teaching Rounds (1 hour/week) 2008- Cardiac Electrophysiology Ambulatory Clinic Elective (4 hours/week)

2008- Director, Cardiac EP Journal Club (1.5 hours/month) 2008- Director, Cardiac EP Works-in-progress seminar (1.5 hours/month)

2008- Cardiology Fellows Morning Report (1 hour/month) 2008- Cardiology Fellows Journal Club (1.5 hours/month)

2011- Associate Director, VA Cardiology Ambulatory Medical Student Rotation 2010- Lecturer, Med 223 Course, Stanford School of Medicine (3 hours per course) PREDOCTORAL STUDENTS SUPERVISED OR MENTORED Dates Name & Program Role Current Position 2005-2006 Mridhula Kumar, UCB Undergraduate Career MPH student (UCLA) 2006-2007 Nance Yuan, UCB Undergraduate Career Medical student (JHU) 2006-2007 Joyce Yuan, UCB Undergraduate Career Medical student (UCLA) 2006-2007 Kaye Jaramillo RNP, UCSF NP Program Research Genomics NP (Kaiser) 2008- Elena Flowers RN Research PhD Candidate (UCSF) 2009- Megha Prasad, BS Research Medical Student (USC) 2009- Donald Hoang, BA Research Pre-medical (Stanford) 2010- Aditya Ullal, BA Research Pre-medical (UC Berkeley) POSTDOCTORAL TRAINEES DIRECTLY SUPERVISED OR MENTORED Dates Name & Program Role Current Position 2008-09 Ron Lo MD, Stanford Career/Research EP Practice (private)


2008-10 Anurag Gupta MD, Stanford Career/Research EP Practice (private) 2008-11 Marco Perez MD, Stanford Career EP Faculty (Stanford) 2009-12 Monica Divakaruni MD, Stanford Research Interventional Fellow 2009-11 Karin Chia MD, PhD, Stanford Research EP Practice (academic) 2009-11 John Evans MD, Stanford Research EP Practice (private) 2009-11 Christine Welles MD, UCSF Research Postdoctoral Fellow 2009-2012 Christopher Woods MD PhD, Stanford Career/Research Research Fellow 2009- James Freeman MD MPH, Stanford Career/Research EP Fellow 2011- Jared Miller MD, Stanford Research Medical Resident PERSONAL Interests Cycling, skiing, cooking.


PEER-REVIEWED PUBLICATIONS Journal Articles

1. Plattner O, Xiong J, Sessler DI, Schmied H, Christensen R, Turakhia MP, Dechert M, Clough D: Rapid core-to-peripheral tissue heat transfer during cutaneous cooling. Anesth Analg 1996; 82:925-930.

2. Plattner O, Ikeda T, Sessler DI, Christensen R, Turakhia MP: Postanesthetic vasoconstriction slows postanesthetic peripheral-to-core transfer of cutaneous heat, thereby isolating the core thermal compartment. Anesth Analg 1996; 85(4):899-906, 1996.

3. Kim JS, Ikeda T, Sessler DI, Turakhia MP, Jeffrey R: Epidural anesthesia reduces the gain and maximum intensity of shivering. Anesthesiology 1998; 88:851-857.

4. Ikeda T, Sessler DI, Tayefeh F, Negishi C, Turakhia MP, Marder D, Biorksten AR, Larson, MD: Meperidine and alfentanil do not reduce the gain or maximum intensity of shivering. Anesthesiology 1998; 88:858-865.

5. Ikeda T, Kim JS, Sessler DI, Negishi C, Turakhia MP, Jeffrey R: Isoflurane alters shivering patterns and reduces maximum shivering intensity. Anesthesiology 1998; 88:866-873.

6. Gibson CM, Gibson WJ, Murphy SA, Marble SJ, McCabe CH, Turakhia MP, Kirtane A, Karha JK, Giugliano RP, Antman EM, Braunwald E, for the TIMI Study Group: The Association of the Fibonacci Cascade with the Distribution of Coronary Artery Lesions Responsible for ST Segment Elevation Myocardial Infarction. Am J Cardiol 2003; 92:595-597.

7. Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM, for the TIMI Study Group: Sequential Risk Stratification Using TIMI Risk Score and TIMI Flow Grade Among Patients Treated with Fibrinolytic Therapy for ST-Segment Elevation Acute Myocardial Infarction. Am J Cardiol 2004; 94:1113-1117.

8. Turakhia MP, Karmpaliotis D, Murphy SA, Pinto T, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM, for the TIMI Study Group: High platelet count in ST segment elevation myocardial infarction is associated with persistent thrombus after fibrinolytic therapy. Am J Cardiol 2004; 94:1406-1410.

9. Turakhia MP, Varosy P, Lee K, Tseng ZH, Lee R, Badhwar N, Scheinman M, Lee BK, Olgin JE: Impact of Renal Function on Survival in Patients with Implantable Cardioverter-Defibrillators. Pacing and Clin Electrophys 2007; 30(3):377-385.

10. Turakhia MP, Tseng ZH. Sudden Cardiac Death, Current Probl Cardiology 2007; 32(9):501-546. 11. Turakhia MP, Kim AM, Lee BK: Use of magnetic catheter navigation for ablation of focal

tachycardias. EP Lab Dig 2007; October. 12. Doroodchi H, Casebeer L, Abdolrasulnia M, Foster JA, Crumly J, Foster E, Sagar K, Turakhia

MP, Skelding K: Primary Care Physicians’ Practice Patterns and Barriers to Management of Patients at Risk for Cardiovascular Disease. BMC Family Practice 2008; 9(42).

13. Turakhia MP, Schiller NB, Whooley MA: Increased left ventricular mass independently predicts sudden cardiac death in patients with stable coronary disease and normal ejection fraction. Am J Cardiol 2008; 102(9):1131-1135.

14. Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, Badhwar N, Scheinman M, Lee BK, Varosy P: Impact of Advanced Age on Survival in Patients with Implantable Cardioverter-Defibrillators. Europace 2008 Nov;10(11):1296-301.

15. Turakhia MP, Grubb BG, Gregoratos G: The Irritable Heart. J Hosp Med 2008; 3(5):423-429. 16. Kim AM, Turakhia MP, Lu JT, Badhwar N, Lee BK, Scheinman M, Marcus GM, Tseng ZH, Olgin

JE: Impact of Remote Magnetic Catheter Navigation on Ablation Procedure and Fluoroscopy Time. Pacing and Clin Electrophys 2008 Nov;31(11):1399-40.

17. Turakhia MP, Prasad M, Olgin JE, Badhwar N, Tseng ZH, Lee RJ, Marcus GM, Lee BK: Rates and Severity of Perforation from Implantable Cardioverter-Defibrillator Leads: A Four-Year Study. J Interv Card Electrophysiol. 2009 Jan;24(1):47-52.


18. Davis BA, Hoffmayer K, Turakhia MP, Goldschlager N: Polymorphic VT? J Hosp Med. 2009 Feb;4(2):140-141.

19. Turakhia MP, Scheinman M, Badhwar M: Featured Arrhythmia: Wolf-Parkinson-White syndrome: where is the pathway? Indian Pacing Electrophysiol J. 2009; 9(2):130-133.

20. Turakhia MP, McManus D, Whooley M, Schiller NB: Increase in End-Systolic Volume with Exercise Independently Predicts Mortality: Data from the Heart & Soul Study. Eur Heart J. 2009 Oct;30(20):2478-84.

21. Ristow B, Ali S, Na B, Turakhia MP, Whooley M, Shiller NB: Predicting Heart Failure Hospitalization and Mortality by Quantitative Echocardiography: Is Body Surface Area the Indexing Method of Choice? The Heart and Soul Study. J Am Soc Echocardiogr. 2010 Apr;23(4):406-13.

22. Perez MV, Al-Ahmad A, Wang PJ, Turakhia MP: Inappropriate Pacing in a Patient with Managed Ventricular Pacing (MVP): What is the cause? Heart Rhythm. 2010 Apr 29. [Epub ahead of print]

23. Al-Khatib SM, Calkins H, Eloff BC, Kowey P, Hammill SC, Ellenbogen KA, Marinac-Dabic M, Waldo AL, Brindis R, Wilbur D, Jackman WM, Yaross MS, Russo A, Prystowsky E, Varosy P, Gross T, Pinnow E, Turakhia MP, Krucoff MW. Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: A Cardiac Safety Research Consortium ‘Incubator’ Think Tank. Am Heart J. 2010;160:619-626.e1.

24. Flowers E, Molina C Mathur A, Prasad M, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia MP. Prevalence of the Metabolic Syndrome in South Asians. Metab Syndr Relat Disor. 2010;8(5):417-423.

25. Freeman JV, Zhu RP, Bobulsky SC, Owens, DK, Garber AM, Turakhia MP: Cost-effectiveness of Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation. Ann Intern Med. 2011; 4;154(1):1-11. Epub November 3, 2010.

26. Turakhia MP: Sudden Cardiac Death and Implantable Cardioverter-Defibrillators. Am Fam Physician. 2010;82(11):1357-1366.

27. Turakhia MP, Heidenreich PA. Using Restriction to Minimize Bias in Observational Studies [letter]. JAMA. 2010;304(21):2359.

28. Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among patients with coronary heart disease: data from the Heart and Soul Study. Am Heart J. 2011 Sep;162(3):555-61. Epub Aug 9, 2011.

29. Uberoi A, Jain NA, Perez M, Weinkopff A, Ashley A, Turakhia MP, Froelicher Vic. Early Repolarization in an Ambulatory Clinical Population. Circulation. 2011 Nov 15;124(20):2208-14. Epub October 10, 2011.

30. Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP. Left atrial dysfunction Predicts Heart Failure Hospitalization In Subjects With Preserved Ejection Fraction And Coronary Heart Disease: Longitudinal Data from the Heart & Soul Study. J Am Coll Cardiol 2012;59:673–80.

31. Gupta A, Karliner L, Feldman M, Tice J, Heidenreich P, Wang PJ, Turakhia MP: Ability of Microvolt T-Wave Alternans to Modify Risk Assessment of Ventricular Tachyarrhythmic Events: A Meta-Analysis. Am Heart J 2012;163:354-64.

32. Perez MV, Uberoi A, Jain NA, Ashley E, Turakhia MP, Froelicher V. Prognostic Value of Early Repolarization in African Americans. Heart Rhythm. 2012 Apr;9(4):558-65. Epub 2011 Nov 15.

33. Woods C, Friday K, Wang PJ, Turakhia M. Abrupt bradycardia and grouped beating during treadmill testing: a mimic of upper rate behavior. Heart Rhythm. 2012 Jul;9(7):1165-7. Epub 2011 Dec 30.

34. Cheng Z, Turakhia MP, Lo R, Gupta A, Zei PC, Hsia HH, Al-Ahmad A, Wang PJ: Incidence, predictors and treatment strategies of inadequate defibrillation safety margin of implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator. J Interv Card Electrophysiol. 2012 Jun;34(1):93-100. Epub 2012 Mar 6.


35. Turakhia MP, Estes NA, Drew B, Granger CB, Wang PJ, Knight B, Page RL. Latency of Visual ECG Displays of Hospital Telemetry Systems: A Science Advisory from the American Heart Association. Circulation. Sep 25;126(13):1665-1669. Epub 2012 Aug 27.

36. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, Turan TN, Wood K. Oral Antithrombotic Agents for the Prevention of Stroke in Non-valvular Atrial Fibrillation: A Science Advisory from the American Heart Association and American Stroke Association. Stroke. Aug 2 2012. [Epub ahead of print]

37. Aleong RG, Turakhia MP, Pellegrini CN, Sauer WH, Yang Y, Heidenreich PA, Mulkerin J, Massie BM, Varosy P. Clinical Subtype of Atrial Fibrillation and Heart Failure Outcomes among Veterans with Implantable Defibrillators. J Am Coll Cardiol. In Press.

38. Goldstein B, Arce CM, Hlatky MA, Turakhia MP, Setogutchi S, Winkelmayer W. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 6;126(19):2293-301.

39. Shen JI, Turakhia MP, Winkelmayer WC. Anticoagulation for Atrial Fibrillation in Patients on Dialysis: Are the Benefits Worth the Risks? Curr Opin Nephrol Hypertens 2012, 21:600–606.

40. Turakhia MP, Hoang DD, Xu X, Frayne SM, Schmitt S, Yang F, Phibbs C, Than CT, Wang PJ, Heidenreich P. Differences and trends in stroke prevention anticoagulation in primary care versus cardiology specialty management of new atrial fibrillation: the TREAT-AF study. Am Heart J 2013;165:93-101.e1.

41. Turakhia MP, Ullal A, United States Health Care Policy and Reform: Implications for Cardiac Electrophysiology. Journal of Interventional Cardiac Electrophysiology. In Press.

42. Lenihan CR, Montez-Rath ME, Scandling JD, Turakhia MP, Winkelmayer WC. Outcomes after Kidney Transplantation of Patients Previously Diagnosed with Atrial Fibrillation. In Press.

43. Johnson CJ, Scheinman MA, Turakhia MP: Challenges in Clinical Electrocardiography: Bizarre and Wide QRS after Liver Transplant. JAMA Internal Medicine. In Press.

44. Divakaruni M, Flowers E, Molina C Mathur A, Prasad M, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia MP: Relationship of Lp(a) to metabolic syndrome in South Asians. Submitted.

45. Freeman JV, Hutton D, Zhu RP, Owens, DK, Garber AM, Hlatky M, Heidenreich P, Al-Ahmad A, Wang PJ, Turakhia MP: Cost-effectiveness of Percutanous Closure of the Left Atrial Appendage for Stroke Prevention in Nonvalvular Atrial Fibrillation. Submitted.

46. Lakdawalla D, Turakhia MP, Jhaveri M, Mozafarri E, Davis P, Bradley L, Solomon M. The Comparative Effectiveness of Antiarrhythmic Therapies on Cardiovascular Hospitalization and Cardiovascular Mortality in Atrial Fibrillation: A Systematic Review. Submitted.

47. Turakhia MP, Solomon M, Jhaveri M, Davis P, Eber MR, Conrad R, Summers N, Lakdawalla L. Association between Cardiovascular Hospitalization and Mortality among Medicare Beneficiaries with Atrial Fibrillation. Submitted.

48. Wong J, Welles CC, Whooley MA, Schiller NB, Turakhia M. Left atrial dysfunction and risk of ischemic stroke in patients with coronary heart disease: findings from the Heart and Soul Study. Submitted.

49. Eapen ZJ, Mi X, Fonarow G, Turakhia MP, Heidenreich PA, Peterson ED, Curtis LH, Hernandez AF, Al-Khatib SM. Warfarin After Hospital Discharge in Patients with Heart Failure and Atrial Fibrillation: Findings from Get With The Guidelines-Heart Failure and Medicare Linked Database. Submitted.

50. Turakhia MP, Hoang DD, Miller JD, Zimetbaum P, Froelicher V, Kumar UN, Yang F, Heidenreich PA. Clinical Experience and Diagnostic Yield from a National Registry of 14-Day Ambulatory ECG Patch Monitoring. Submitted.

51. Gupta A, Gholami P, Turakhia MP, Friday K, Heidenreich P. Clinical Reminders to Providers of Patients with Reduced Left Ventricular Ejection Fraction Increase Defibrillator Referral: A Randomized Trial. Submitted.


52. Heidenreich P, Tsai V, Curtis J, Wang Y, Turakhia MP, Masoudi F, Varosy P, Goldstein M. A Validated Risk Model for One Year Mortality after Primary Prevention Implantable Cardioverter Defibrillator Placement. In preparation.

NON PEER-REVIEWED PUBLICATIONS Articles

1. Turakhia MP: Insulin resistance and atherosclerosis: piecing together the mystery of the metabolic syndrome. Cardiology Report July, 2005

2. Turakhia MP, Wang PJ: ICD "Prophylaxis" in the Elderly: Call for a Randomized Trial? Heart Rhythm. 2009; 6(8):1144-1145

3. Turakhia MP: Quality of premarket approval studies submitted to FDA for invasive and implantable cardiovascular devices. White paper. Published in syllabus and presented as part of Stanford Materials Science & Engineering 256 course: Technology Assessment and Regulation of Medical Devices. April 13, 2010.

4. Perez MV, Al-Ahmad A, Wang PJ, Turakhia MP. Letter Reply (Inappropriate Pacing in a Patient with Managed Ventricular Pacing (MVP): What is the Cause?). Heart Rhythm. 2010. [Epub ahead of print].

5. Turakhia MP. Quality of Stroke Prevention Care in Atrial Fibrillation: Many Moving Targets. Circulation: Circ Cardiovasc Qual Outcomes. 2011;4(1):5-8

6. Freeman JV, Ullal A, Turakhia MP. Cost-Effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Advances in ICD Therapy. Cardiac Electrophysiology Clinics. 2011; 3(3): 421-440.

7. Freeman JV, Turakhia MP. Cost-effectiveness of Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation [letter reply]. Ann Intern Med. 2011 Apr;154(8): 570-1.

8. Solomon MD, Ullal A, Hoang D, Freeman JV, Heidenreich PA, Turakhia MP. Cost-Effectiveness of Pharmacologic and Invasive Therapies for Stroke Prophylaxis in Atrial Fibrillation. J Cardiovasc Med. 2012 Feb;13(2):86-96.

9. Prasad M, Truong J, Wu G, Turakhia MP. Coronary Artery Disease in South Asians. J Asian Health. 2012; 04:42. (online only www.journalofasianhealth.com)

10. Turakhia MP. JICE goes “social”. J Interv Card Electrophysiol. 2011 Nov;32(2):79-80. Epub 2011 Oct 5.

11. Shalaby AA, Turakhia MP, Varosy PD. Cardiac Electrophysiology Services in VA Health Care. Federal Practitioner. 2012. In Press.

12. Turakhia M, Gupta A. Letter Reply: Ability of Microvolt T-Wave Alternans to Modify Risk Assessment of Ventricular Tachyarrhythmic Events: A Meta-Analysis [letter reply]. Am Heart J. 2012 Oct;164(4):e9-e10.

13. Hlatky M, Reynolds MR, Turakhia MP. Foreword to Health Policy Issue. J Interv Card Electrophysiol. 2013. Epub.

Book chapters 1. Nguyen T, Turakhia MP, Tien PH, Wang L, Gibson CM: Chapter 12: Management of ST

Segment Elevation Myocardial Infarction, Practical Handbook of Advanced Interventional Cardiology, 2/ed (2003), 680 pp., Futura Publishing. ISBN 1405117311.

2. Reynolds MR, Turakhia MP, Pinto DS, Josephson ME. Chapter 17: Sudden Cardiac Death. Hurst’s Manual of Cardiology, 12/ed (2009), pg. 207-216, McGraw-Hill Publishers. ISBN 9780071592987.

3. Perez MV, Hsia H, Zei PC, Turakhia MP, Wang PJ, Al-Ahmad M. Automatic Threshold Measuring Algorithms. Pacemakers and Implantable Defibrillators: An Expert’s Manual, 1/ed (2010), Cardiotext Publishing. ISBN 9780979016462.


4. Wang PJ, Al-Ahmad M, Hsia H, Zei PC, Turakhia MP. Programming to Avoid Phrenic Nerve Stimulation During Left Ventricular Pacing. Pacemakers and Implantable Defibrillators: An Expert’s Manual, 1/ed (2010), Cardiotext Publishing. ISBN 9780979016462.

5. Chen H, Al-Ahmad A, Hsia HH, Turakhia MP, Zei PC, Wang PJ. Ablation of Mahaim Fiber Accessory Pathways. Cardiac Electrophysiology. Edited by Huang & Wood. 2/ed (2010). Cardiotext Publishing. ISBN 9781437713688.

6. Evans J, Turakhia MP. How to Ablate Typical and Reverse Typical Atrial Flutter. Hands-On Ablation: The Experts’ Approach. 1st/ed (2012). Cardiotext Publishing. ISBN 9781935395249.

7. Wang PH, Al-Ahmad A, Hsia HH, Zei PC, Turakhia MP. Timing Cycles of Implantable Devices. In: Clinical Cardiac Pacing, Defibrillation, and Resychronization Therapy. 4/ed (2011). Elsevier Health Sciences Publishing. ISBN 9781437716160.

8. Evans J, Turakhia MP, Hsia H, Zei P, Perez M, Wang PJ, Al-Ahmad A. Cardiac Devices and Radiography. In press.

9. Wang PJ, Al-Ahmad A, Hsia HH, Zei PC, Turakhia MP, Perez M, Eversull CS. Intraprocedural Techniques: Angioscopy and Optical Mapping. In: Cardiac Imaging in Electrophysiology. 1/ed (2012). Springer. Pp. 149-159. ISBN 9781848824850.

10. Turakhia M. Strategies for Medical Device Design Focused on Outcomes and Cost. In: Wang PJ, Yock PG, Hsia HH, Al-Ahmad A, Turakhia MP, Zei PC, Perez MV, eds. Advances in Arrhythmia Technologies. Cardiotext. In Press.

11. Yang F, Turakhia M, Froelicher V. Exercise-Induced Arrhythmias. In: Zipes D, Jalife J: Cardiac Electrophysilogy: From Cell to Bedside, 6/E. Elsevier. In Press.

On-line Publications 1. “Infective Endocarditis.” December 2004. www.firstconsult.com 2. “Aortic Stenosis,” March 2005. www.firstconsult.com 3. “Atrial Myxoma,” October 2005. www.firstconsult.com 4. “Cardiac Resynchronization Therapy,” January 2006. www.medcompare.com 5. “Carotid Sinus Hypersensitivity,” January 2006. www.firstconsult.com 6. “Use of Microvolt T-Wave Alternans for Risk Stratification in Sudden Cardiac Death,” April 2006.

www.medcompare.com ABSTRACTS

1. Plattner O, Ikeda T, Sessler DI, Christensen R, Turakhia MP: Does postoperative forced-air warming speed core temperature rewarming? American Society of Anesthesiology, 1996

2. Kwong R, Turakhia MP, Reynolds HG, Skorstad R, Yucel EK: Multislice MRI Myocardial Perfusion at High Heart Rates during Dobutamine/Atropine Stress is Feasible and has Higher Sensitivity than MRI Cine in the Detection of Coronary Artery Disease. 2002 American Heart Association (AHA) Scientific Sessions.

3. Kwong R, Winslow R, Blount J, Turakhia MP, Solomon S, Yucel EK, Giri S: First-pass MRI Myocardial Perfusion Can Determine Microvascular Dysfunction in Acute Myocardial Infarction: Validation Against Angiographic TIMI Frame Count and Myocardial Blush Score. 2003 American College of Cardiology (ACC) Scientific Sessions.

4. Turakhia MP, Kwong R, Reynolds HG, Skorstad R, Yucel EK: Dobutamine Stress Myocardial Perfusion with MRI: Feasibility Study. Harvard University / Brigham and Women’s Hospital 2003 Resident Research Symposium.

5. Turakhia MP, Karmpaliotis D, Morrow DA, Murphy SA, Kirtane AJ, Kosmidou I, Marble SJ, Giugliano RP, McCabe CH, Braunwald E, Gibson CM. Sequential Risk Stratification Using the TIMI Risk Score and the TIMI Flow Grade Among Patients Treated with Fibrinolytic Therapy for Acute ST Segment Elevation Myocardial Infarction. 2003 AHA Scientific Sessions.


6. Turakhia MP, Gregoratos G. 30-Year Old Woman With Palpitations, Syncope, and Unilateral Extremity Arterial Spasm After Cervical Spine Surgery. 2005 AHA Scientific Sessions.

7. Turakhia MP, Ali S, Schiller NB, Whooley MA. Evaluation of Left Ventricular Mass and Mortality in Patients with Stable Coronary Disease. 2006 AHA Western States Young Investigators Meeting.

8. Turakhia MP, Schiller NB, Whooley MA. Increase in End-Systolic Volume with Exercise Independently Predicts Mortality: Data from the Heart & Soul Study. 2006 AHA Scientific Sessions.

9. Turakhia MP, Ali S, Schiller NB, Whooley MA. Left Ventricular Mass Predicts Death and Sudden Death in Patients with CAD Regardless of Ejection Fraction: Data from the Heart & Soul Study. 2006 AHA Scientific Sessions.

10. Turakhia MP, Yong P, Schafer J, De Marco T, for the CONTAK-CD Investigators. Diminished Benefit of Cardiac Resynchronization in Subjects with Low or Preserved Baseline Left Ventricular End-Systolic Dimension. 2008 Heart Rhythm Society Scientific Sessions.

11. Lu JT, Viswanathan M, Kim AM, Turakhia MP, Badhwar N, Lee BK, Tseng ZH, Marcus GM, Lee RJ, Olgin JE, Scheinman M. Use of Parahisian Entrainment to Differentiate Mechanisms of Supraventricular Tachycardia. 2008 Heart Rhythm Society Scientific Sessions.

12. Turakhia MP, Yong P, Schafer J, De Marco T, for the CONTAK-CD Investigators. Prognostic significance of baseline left ventricular volume to response to cardiac resynchronization. 2008 CARDIOSTIM scientific sessions.

13. DeMarco T, Lee BK, Linenfeld J, Saxon LA, Boehmer J, Turakhia MP, Leigh J, Yong P, Curran C, Feldman AM, Bristow MR: Influence of Left Ventricular End Diastolic Diameter Index on Clinical Outcomes with Cardiac Resynchronization: Insights from the COMPANION Study. 2008 AHA Scientific Sessions.

14. Lo R, Perez M, Gupta A, Tam F, Natale A, Turakhia MP, Hsia HH, Zei PC, Wang PJ, Al-Ahmad A. A novel method of pressure measurements in cardiac chambers utilizing irrigated tip ablation catheters. 2009 Heart Rhythm Society Scientific Sessions, Boston, May 15, 2009.

15. Eversull CS, Lin B, Quigley ML, Mourlas NJ, Al-Ahmad A, Hsia HH, Zei PC, Turakhia MP, Wang PJ. Direct Intracardiac Visualization of Radiofrequency Catheter Ablation Lesions. 2009 Heart Rhythm Society Scientific Session, Boston, May 15, 2009.

16. Phibbs CS, Le S, Schmidt S, Turakhia MP, Frayne SM. Impact of Dual Use of VA and Medicare in Outcomes in Patients with Atrial Fibrillation. 2009 Academy Health Scientific Meeting, Chicago, June 28, 2009.

17. Joseph SA, Yang Y, Ng RK, Narayan SM, Varosy P, Kumar UN, Rao R, Turakhia MP, Keung EC, Badhwar N, Lee BK, Tseng ZH, Olgin JE, Scheinman M. Atypical ECG Characteristics of Atrial Flutter as an Exclusion to Ablation: A Missed Opportunity. 2009 Cardiac Society of Australia and New Zealand Annual Scientific Meeting, August 14, 2009.

18. Gupta A, Turakhia MP, Heidenreich P. Predictors of Defibrillator Implantation in an Eligible VA Population. California Heart Rhythm Symposium, San Francisco, September 9, 2009.

19. Flowers E, Molina C Mathur A, Prasad M, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia MP. Predictors of the Metabolic Syndrome in South Asians. Bay Area Clinical Research Symposium, October 28, 2009.

20. Flowers E, Molina C Mathur A, Prasad M, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia MP. Prevalence of the Metabolic Syndrome in South Asians Residing in the United States. UCSF Health Disparities Symposium, October 23, 2009.

21. Prasad M, Flowers E, Molina C Mathur A, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia MP. Metabolic Syndrome in South Asians: Nature or Nurture? Indian Medical Association of California, 2009.

22. Turakhia MP, Phibbs C, Schmitt S, Moos R, Heidenreich P, Le S, Frayne S. Systematic Variation of Facility Quality of Anticoagulation for Atrial Fibrillation: A National VA Study. VA HSR&D Career Development Awardee Conference, San Francisco CA, February 25, 2010.


23. Divakaruni M, Prasad M, Flowers E, Molina C Mathur A, Abrams L, Sathe A, Malhotra D, Basra R, Malgesini N, Ratman G, Aouizerat BE, Turakhia MP. Inverse association of Lp(a) concentration with metabolic syndrome components in South Asians. American College of Cardiology Scientific Sessions, March 14, 2010.

24. Frayne SM, Turakhia MP, Schmitt SK, Friedman SA, Chiu VY, Moos RH, Heidenreich P, Berlowitz D, Phibbs CS. Atrial Fibrillation Management in Patients with Mental Illness: Are they Anticoagulated? Are They Monitored? Health Services & Research and Development Meeting on Mental Health and Substance Use Disorders, February 25, 2010.

25. Phibbs CS, Friedman SA, Turakhia MP, Chiu VY, Moos RH, Schmitt SK, Le SY, Frayne SM. Are Atrial Fibrillation Patients With Mental Health Conditions Treated Differently? Are Atrial Fibrillaton Patients with Mental Health Conditions Treated Differently? Poster presentation at Society of General Internal Medicine Annual Meeting, Minneapolis MN, April 28, 2010.

26. Chiu VY, Turakhia MP, Phibbs CS, Moos RH, Schmitt SK, Le SY, Friedman SA, Frayne SM. Time to next INR as an anticoagulation quality measure in atrial fibrillation. Poster presentation at Society of General Internal Medicine Annual Meeting, Minneapolis MN, April 28, 2010.

27. Turakhia MP, Zhu RP, Bobulsky SC, Owens, DK, Garber AM, Freeman JV. Cost-effectiveness of Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation. Poster presentation at Heart Rhythm Society Scientific Sessions, May 13, 2010.

28. Turakhia MP, Phibbs CS, Schmitt SK, Heidenreich P, Frayne SM. Facility Variation in Quality of Anticoagulation is Directly Related to Facility INR Test Frequency: A National VA Study. Poster presentation at Heart Rhythm Society Scientific Sessions, May 14, 2010.

29. Freeman JV, Zhu RP, Bobulsky SC, Owens, DK, Garber AM, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation. Oral presentation at Heart Rhythm Society Scientific Sessions, May 14, 2010.

30. Gupta A, Hoang DH, Karliner L, Tice J, Turakhia M. Ability of Microvolt T-Wave Alternans to Modify Pre-Test Risk of Ventricular Tachyarrhythmic Events: A Meta-Analysis. Oral presentation at Heart Rhythm Society Scientific Sessions, May 14, 2010.

31. Cheng Z, Zei PC, Hsia HH, Al-Ahmad A, Turakhia MP, Daubert J, Zareba W, Moss AJ, Wang PJ. One Train of Antitachycardia Pacing is Successful For Fast Ventricular Tachycardia in Patients with Conduction Abnormalities and Left Ventricular Dysfunction: Results from the MADIT-CRT study. Poster presentation at Heart Rhythm Society Scientific Sessions, May 14, 2010.

32. Turakhia MP, Phibbs CS, Moos R, Friedman S, Heidenreich P, Frayne SM. Facility volume is not associated with increased quality of anticoagulation care for patients with atrial fibrillation. Poster presentation at AHA Quality of Care and Outcomes Research Scientific Sessions, May 21, 2010.

33. Turakhia MP, Gupta A, Hoang DH, Tice J, Karliner L. Diagnostic Test Performance of Microvolt T-Wave Alternans: A Meta-Analysis. Oral presentation at CARDIOSTIM Scientific Sessions, Nice, France, June 14, 2010.

34. Turakhia MP, Zhu RP, Bobulsky SC, Owens, DK, Garber AM, Al-Ahmad A, Wang PJ, Freeman JV. Cost-effectiveness of percutaneous left atrial appendage occlusion versus warfarin for atrial fibrllation. Poster presentation at CARDIOSTIM Scientific Sessions, Nice, France, June 14, 2010.

35. Wang PJ, Al-Ahmad A, Evans J, Turakhia MP, McNitt S, Moss AJ, Zareba W. Cardiac Resynchronization Therapy Decreases the Risk of Ventricular Tachyarrhythmias in the MADIT-CRT Trial. Poster presentation at American Heart Association Scientific Sessions, November 15, 2010.

36. Frayne SM, Turakhia MP, Schmitt SK, Friedman SA, Chiu VY, Moos RH, Heidenreich P, Berlowitz D, Phibbs CS. Atrial Fibrillation Management in Patients with Mental Illness: Are they Anticoagulated? Are They Monitored? Poster presentation at HSR&D National Meeting, February 25, 2011.

37. Welles CC, Na B, Whooley MA, Turakhia MP. CHADS2 Score Predicts Ischemic Stroke in the Absence of Atrial Fibrillation Among Patients With Coronary Heart Disease: Data from the Heart and Soul Study. Poster presentation at American College of Cardiology Scientific Sessions, New Orleans, April 5, 2011.


38. Turakhia MP, Xu X, Hoang D, Heidenreich P. Differences and trends in stroke prevention guideline adherence in primary care versus cardiology specialty management of new atrial fibrillation: the TREAT-AF study. Poster presentation at 2011 Heart Rhythm Society Scientific Sessions, San Francisco, May 7, 2011.

39. Turakhia MP, Xu X, Hoang D, Heidenreich P. Differences in medical therapy in primary care versus cardiology specialty management of new atrial fibrillation: the TREAT-AF study. Poster presentation at 2011 Heart Rhythm Society Scientific Sessions, San Francisco, May 7, 2011.

40. Perez MV, Oberoi A, Jain NA, Weinkopff A, Ashley E, Turakhia MP, Froelicher V. Differences in Prevalence and Prognosis of Early Repolarization Between African Americans and other Ethnic Groups. Poster presentation at 2011 Heart Rhythm Society Scientific Sessions, San Francisco, May 7, 2011.

41. Frayne SM, Turakhia MP, Moos RH, Friedman SA, Schmitt SK, Berlowitz D, Phibbs CS. Anticoagulation Outcomes in Atrial Fibrillation: Impact of Mental Illness. Poster presentation at Academy Health, Seattle, WA, June 13, 2011.

42. Frayne SM, Turakhia MP, Moos RH, Friedman SA, Schmitt SK, Berlowitz D, Phibbs CS. Anticoagulation Outcomes in Atrial Fibrillation: Impact of Mental Illness. Oral presentation at Society of General Internal Medicine National Meeting, Phoenix AZ, May 6, 2011.

43. Welles CC, Ku I, Whooley MA, Schiller NB, Turakhia MP. Left Atrial Function Predicts Heart Failure Hospitalization in Patients with Stable Coronary Artery Disease and Normal Ejection Fraction: Data from the Heart and Soul Study. Poster presentation at AHA Quality of Care and Outcomes Research Meeting, Washington DC, May 13, 2011.

44. Frayne SM, Turakhia MP, Moos RH, Friedman SA, Schmitt SK, Berlowitz D, Phibbs CS. Anticoagulation Outcomes in Atrial Fibrillation: Impact of Mental Illness. Oral presentation at AcademyHealth Annual Research Meeting, Seattle, June 13, 2011.

45. Solomon M, Lakdawalla D, Turakhia MP, Jhaveri M, David P, Bradley L. Comparative Effectiveness Of Antiarrhythmic Drug Therapy In Atrial Fibrillation: Focus On Cardiovascular Hospitalization And Mortality Outcomes. Poster presentation at the Society for Medical Decision Making, Chicago, October 25, 2011.

46. Hoang DD, Ullal A, Perez MV, Froelicher VF, Heidenreich PA, Yang F, Turakhia MP. Early Repolarization Pattern on ECG and Risk of Arrhythmic Death: A Systematic Review. Poster presentation at Bay Area Clinical Research Symposium, San Francisco, November 4, 2011.

47. Yang F, Xu X. Hoang DD, Heidenreich PA, Turakhia MP. Warfarin use in veterans with incident atrial fibrillation and severe renal dysfunction. Poster presentation at Bay Area Clinical Research Symposium, San Francisco, November 4, 2011.

48. Gupta A, Gholami P, Turakhia MP, Friday K, Heidenreich P. Clinical Reminders to Providers of Patients with Depressed Left Ventricular Ejection Fraction Increase Defibrillator Implantation: A Randomized Trial. Oral presentation at 2011 American Heart Association Scientific Sessions, Orlando, FL, November 15, 2011.

49. Flowers E, Molina C, Mathur A, Aouizerat B, Turakhia MP. Lipoprotein Levels and Composition in South Asians Compared to the US Population. Poster presentation at 2012 AHA EPI/NPAM Scientic Sessions, San Diego, CA, March 13, 2012.

50. Turakhia MP, Solomon M, Jhaveri M, Davis P, Conrad R, Summers N, Lakdawalla D. Association of cardiovascular hospitalization to mortality in newly-diagnosed Atrial Fibrillation. Poster presentation at American College of Cardiology Scientific Sessions, Chicago IL, March 26, 2012.

51. Turakhia MP, Yang F, Xu X, Winkelmayer W, Hoang D, Heidenreich P. Amiodarone use is not associated with mortality in patients with atrial fibrillation and kidney dysfunction or dialysis: the TREAT-AF study. Poster presentation at American College of Cardiology Scientific Sessions, Chicago IL, March 26, 2012.

52. Turakhia MP, Yang F, Xu X, Winkelmayer W, Hoang D, Heidenreich P. Interaction among digoxin use, kidney function, and mortality in patients with atrial fibrillation: the TREAT-AF study.


Poster presentation at American College of Cardiology Scientific Sessions, Chicago IL, March 26, 2012.

53. Turakhia MP, Hoang D, Zimetbaum P, Yang F, Heidenreich P, Froelicher V. Clinical Experience and Diagnostic Yield from a National Registry of 14-day Ambulatory ECG Patch Monitoring. Poster presentation at American College of Cardiology Scientific Sessions, Chicago IL, March 26, 2012.

54. Yang F, Xu X, Winkelmayer W, Hoang D, Than C, Heidenreich P, Turakhia MP. Warfarin Use And Bleeding Risk In Veterans With Incident Atrial Fibrillation And Severe Chronic Kidney Disease: The TREAT-AF Study. Poster presentation at Heart Rhythm Society Scientific Sessions, Boston MA, May 11, 2012.

55. Turakhia MP, Xu X, Yang F, Hoang D, Than C, Heidenreich P. Bleeding Risk Differentially Affects Warfarin Prescription Rates Among Primary Care Versus Cardiology Specialty Management of Newly Diagnosed Atrial Fibrillation: The TREAT-AF Study. Featured poster presentation at Heart Rhythm Society Scientific Sessions, Boston MA, May 8, 2012.

56. Turakhia MP, Than CT, Xu X, Schmitt SK, Yang F, Frayne SM, Phibbs CS, Holmes TH, Heidenreich PA. Impact of Baseline Stroke Risk and Bleeding Risk on INR Control among Patients with AF on Warfarin: Data from the TREAT-AF Study. Oral presentation at American Heart Association Scientific Sessions, Los Angeles CA, November 5, 2012.

57. Jackevicius CA, Ho MP, Xu X, Heidenreich PA, Plomondon M, O’Donnell C, Tsadok M, Pilote L, Tu JV, Turakhia MP. Adherence and Persistence for Antiarrhythmic and Rate Control Agents in Newly Diagnosed Atrial Fibrillation: Findings from the TREAT-AF Study. Submitted to AHA Quality of Care and Outcomes Research Scientific Sessions. May 2013.

58. Turakhia MP, Hunter TD, Mollenkopf SA, Reynolds MR. Rates of Atrial Fibrillation Diagnoses and Stroke Events by Combination of Risk Factors. Submitted to AHA Quality of Care and Outcomes Research Scientific Sessions. May 2013.

59. Turakhia MP, Reynolds MR, Swain A, Mollenkopf SA, Zweibal S. Healthcare Resource Utilization and Expenditures Associated with Implantable Cardioverter Defibrillator Shocks. Submitted to AHA Quality of Care and Outcomes Research Scientific Sessions. May 2013.

60. Than CT, Xu Xiangyan, Schmitt SK, Frayne SM, Phibbs CS, Holmes TH, Heidenreich PA, Moos R, Berlowitz D, Go AS, Turakhia MP. Submitted to AHA Quality of Care and Outcomes Research Scientific Sessions. May 2013.

61. Ullal AJ, Hoang DD, Than C, Heidenreich PA, Miller J, Friday K, Froelicher VF, Turakhia MP. Feasibility of outpatient ambulatory ECG monitoring to screen for silent atrial fibrillation: Pilot Findings from Screening Trial for Undiagnosed Atrial Fibrillation (STUDY-AF). Submitted to AHA Quality of Care and Outcomes Research Scientific Sessions. May 2013.

Minang Pravin Turakhia, M.D. M.A.S.

Documents

Transcript of Minang Pravin Turakhia, M.D. M.A.S.